SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 270 filers reported holding SAGE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13 | -99.9% | 82 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | 0.0% | 82 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | 0.0% | 82 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | +30.0% | 82 | -54.9% | 0.00% | – |
| Q2 2021 | $10,000 | -16.7% | 182 | +6.4% | 0.00% | – |
| Q1 2021 | $12,000 | -25.0% | 171 | -2.8% | 0.00% | -100.0% |
| Q4 2020 | $16,000 | – | 176 | +5766.7% | 0.00% | – |
| Q3 2020 | $0 | – | 3 | – | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2020 | $1,000 | -97.9% | 23 | -96.5% | 0.00% | -100.0% |
| Q4 2019 | $48,000 | -50.5% | 660 | -1.2% | 0.00% | -33.3% |
| Q3 2019 | $97,000 | +4750.0% | 668 | +5972.7% | 0.01% | – |
| Q1 2019 | $2,000 | -95.8% | 11 | -97.9% | 0.00% | -100.0% |
| Q4 2018 | $48,000 | -36.8% | 534 | -0.4% | 0.00% | 0.0% |
| Q3 2018 | $76,000 | -10.6% | 536 | -1.3% | 0.00% | -25.0% |
| Q2 2018 | $85,000 | +8400.0% | 543 | +10760.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 5 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | – | 5 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 5 | -54.5% | 0.00% | – |
| Q1 2016 | $2,000 | +100.0% | 11 | -47.6% | 0.00% | – |
| Q4 2015 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |